Prospective, Placebo-controlled, Double Blind, Randomized Intra-individual Comparative Clinical Study to Assess the Safety and Efficacy of AR/101 Compared to Placebo in Accelerating Re-epithelialization of Split Thickness Wounds

Trial Profile

Prospective, Placebo-controlled, Double Blind, Randomized Intra-individual Comparative Clinical Study to Assess the Safety and Efficacy of AR/101 Compared to Placebo in Accelerating Re-epithelialization of Split Thickness Wounds

Recruiting
Phase of Trial: Phase I/II

Latest Information Update: 22 Jul 2016

At a glance

  • Drugs AR 101 (Primary)
  • Indications Wounds
  • Focus Therapeutic Use
  • Most Recent Events

    • 18 Jul 2016 Planned End Date changed from 1 Oct 2016 to 1 Jun 2017.
    • 18 Jul 2016 Planned primary completion date changed from 1 Oct 2016 to 1 Jun 2017.
    • 20 Nov 2015 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top